Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Early Phase 1

1(16.7%)

Phase 2

1(16.7%)

6Total

N/A(4)

Early Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT02957240Not ApplicableCompleted

Graded Motor Imagery for Women at Risk for Developing Type I CRPS Following Closed Treatment of Distal Radius Fractures

Role: collaborator

NCT02988245Phase 2Unknown

Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension

Role: collaborator

NCT03055260Not ApplicableCompleted

Low Intensity Blood Flow Restriction Training Study

Role: collaborator

NCT02722213Not ApplicableCompleted

Mindfulness & Stress Management Study for Cardiac Patients

Role: collaborator

NCT03292900Completed

Association Between Genetic Algorithm to Predict Hypertension Therapy and Response to Treatment

Role: collaborator

NCT03335384Not ApplicableWithdrawn

Relationship Between PFTs and Pdi in DMD

Role: collaborator

NCT00685555Early Phase 1Completed

Healthy Futures Project: A Community Based Obesity Prevention Program

Role: collaborator

All 7 trials loaded